Novo Holdings β 2023 Investments
5 investments dated 2023 Β· listed companies and verified rows first Β· show all
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more
NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.
BiotechDeep TechHealthtechMedical DevicesAarhus, DK
Co-investorsJeito CapitalRoche Venture FundInkef
Chromologics develops natural red colorants as alternatives to synthetic dyes.
BiotechFoodTechNew MaterialsCopenhagen, DK
Anders Odum(Founder)
Co-investorsBlue Horizon CorporationCollateral GoodNordic Foodtech VCDoehler Ventures
Doctor Anywhere is a technology-driven healthcare company that provides medical care to patients through online and in-person channels.
Digital HealthHealthtechMental Health
Co-investorsOSK Ventures InternationalSquare Peg Capital
HPNow produces hydrogen peroxide (Peroxide UltraPure) on-site through a patented electrochemical process that converts water, electricity, and air into low-concentration, high-purity peroxide for water treatment.
AgTechCircular EconomyCleantechHardwareNew Materials
Co-investorsAP VenturesEvonik Venture Capital GmbH
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.